Internal Medicine · Largo, FL
NPI
1922006865
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8787 Bryan Dairy Rd Ste 230
Largo, FL, 33777
Phone (727) 541-4426
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
3,107 services
Medicare patients, 2024
637
Average age 74
Drug cost, 2024
$4.1M
17,926 prescriptions
Company payments, 2025
$1,972
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kush K Patel was code 99214 (office e&m - established), 1,218 times for 546 patients. In total Kush K Patel billed 3,107 services in 24 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,218 | 546 | $93.20 | $114K |
| 36415 Venipuncture Blood Collection | Office | 1,117 | 560 | $8.57 | $9,567 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 237 | 237 | $132.62 | $31K |
| 99213 Office E&M - Established | Office | 130 | 102 | $65.39 | $8,500 |
| 96372 Injection Administration | Office | 129 | 16 | $9.61 | $1,240 |
| 93000 Electrocardiogram | Office | 75 | 71 | $10.26 | $770 |
| 99212 Office E&M - Established | Office | 71 | 17 | $42.76 | $3,036 |
| 99204 Office E&M - New | Office | 46 | 46 | $116.09 | $5,340 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 27 | 27 | $172.95 | $4,670 |
| 99215 Office E&M - Established | Office | 11 | 11 | $151.51 | $1,667 |
By year: 2022 $152K for 2,826 services; 2023 $169K for 3,167 services; 2024 $182K for 3,107 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,117 | 560 | $8.57 | $9,567 |
Medicare prescription drug claims, 2024
In 2024, the drug Kush K Patel prescribed most often to Medicare patients was Rosuvastatin Calcium, with 710 prescriptions and refills. In total Kush K Patel wrote 17,926 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 710 | 1,877 | 209 | $6,452 |
| Levothyroxine Sodium Generic | 658 | 1,803 | 178 | $6,121 |
| Atorvastatin Calcium Generic | 631 | 1,749 | 185 | $7,107 |
| Alprazolam Generic | 502 | 559 | 104 | $3,476 |
| Amlodipine Besylate Generic | 488 | 1,335 | 136 | $3,070 |
| Zolpidem Tartrate Generic | 348 | 420 | 59 | $2,396 |
| Omeprazole Generic | 317 | 789 | 82 | $5,428 |
| Losartan Potassium Generic | 313 | 855 | 92 | $2,812 |
| Lisinopril Generic | 313 | 824 | 82 | $2,081 |
| Hydrochlorothiazide Generic | 300 | 808 | 89 | $1,471 |
| Metformin Hcl Generic | 296 | 813 | 86 | $1,703 |
| Simvastatin Generic | 289 | 762 | 75 | $2,776 |
| Gabapentin Generic | 285 | 490 | 62 | $3,832 |
| Tamsulosin Hcl Generic | 256 | 638 | 66 | $3,493 |
| Metoprolol Succinate Generic | 238 | 624 | 64 | $3,028 |
Brand drugs: 2,813 claims; generic drugs: 15,046 claims; opioid claims: 468.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kush K Patel $1,972 ($1,972 in general payments such as food, travel and fees) from 17 companies. The largest payer was Gilead Sciences, Inc. with $736.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 47 | $736 |
| ViiV Healthcare Company GSK | 17 | $465 |
| Novo Nordisk Inc NVO | 7 | $136 |
| Abbvie Inc. ABBV | 5 | $127 |
| Exact Sciences Corporation EXAS | 3 | $65.72 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $64.23 |
| GlaxoSmithKline, LLC. GSK | 2 | $60.2 |
| Pfizer Inc. PFE | 3 | $51.13 |
| Lilly USA, LLC LLY | 2 | $49.11 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $47.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.